Preparation method of atherosclerotic mouse model with NOD (Non-Obese Diabetic) genetic background
An atherosclerosis, mouse model technology, applied in the field of genetic engineering and genetic modification, can solve the problem of lack of NOD genetic background mouse gene knockout model, and achieve the effect of saving reagents and time cost, and high shearing efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] The preparation method of the atherosclerosis mouse model of NOD genetic background in this embodiment (flow process is as follows figure 1 shown), including the following steps:
[0053] 1. According to the principle of CRISPR / Cas9 system, use CRISPOR online design software to determine the specific target sites of ApoE (Gene ID: 88057) and LDLR (Gene ID: 96765) in NOD mice sgRNA2, ApoE-sgRNA3 and LDLR-sgRNA1, LDLR-sgRNA2, LDLR-sgRNA3.
[0054] Find the mouse ApoE (Transcript ID: ENSMUST00000174064.8) and LDLR (Transcript ID: ENSMUST00000034713.8) gene DNA sequences in the mouse genome database ensembl (http: / / asia.ensembl.org), and then use the online design software CRISPOR (http: / / crispor.tefor.net / crispor.cgi), determined to select 3 specific sites in exon3 (exon ID: ENSMUSE00000231320) of the mouse ApoE gene and exon4 (exon ID: ENSMUSE00000217581) of the LDLR gene As the target sequence of sgRNA, the three target sequences are:
[0055] ApoE-sgRNA1: CCTAGCCGAGG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com